$0.15
4.07%
Downside
Day's Volatility :9.5%
Upside
5.66%
13.33%
Downside
52 Weeks Volatility :92.26%
Upside
91.07%
Period | Fsd Pharma Inc | Index (Russel 2000) |
---|---|---|
3 Months | -69.06% | 0.0% |
6 Months | -82.46% | 0.0% |
1 Year | -86.25% | 0.0% |
3 Years | -90.89% | -20.2% |
Market Capitalization | 6.6M |
Book Value | $0.3 |
Earnings Per Share (EPS) | -0.25 |
PEG Ratio | 0.0 |
Wall Street Target Price | 2.6 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -33.74% |
Return On Equity TTM | -64.03% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -7.3999999999999995% |
Gross Profit TTM | -3.3M |
EBITDA | -10.6M |
Diluted Eps TTM | -0.25 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.22 |
EPS Estimate Next Year | -0.12 |
EPS Estimate Current Quarter | -0.05 |
EPS Estimate Next Quarter | -0.06 |
What analysts predicted
Upside of 1633.33%
Sell
Neutral
Buy
Fsd Pharma Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Fsd Pharma Inc | -17.04% | -82.46% | -86.25% | -90.89% | -98.04% |
![]() Neurocrine Biosciences Inc. | 7.56% | 2.78% | 45.55% | 52.55% | 67.01% |
![]() Haleon Plc Spon Ads | 7.53% | 11.87% | 3.28% | 23.35% | 23.35% |
![]() Zoetis Inc. | 5.77% | -5.62% | -5.85% | -9.99% | 57.03% |
![]() Viatris Inc. | 12.75% | -1.42% | 12.21% | -15.03% | -28.03% |
![]() Catalent, Inc. | 4.08% | 11.91% | 19.53% | -48.27% | 2.08% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Fsd Pharma Inc | NA | NA | 0.0 | -0.22 | -0.64 | -0.34 | NA | 0.3 |
![]() Neurocrine Biosciences Inc. | 39.75 | 39.75 | 0.44 | 3.99 | 0.18 | 0.1 | NA | 23.72 |
![]() Haleon Plc Spon Ads | 29.9 | 29.9 | 1.69 | 0.39 | 0.07 | 0.04 | 0.02 | 1.8 |
![]() Zoetis Inc. | 34.62 | 34.62 | 2.58 | 5.77 | 0.5 | 0.14 | 0.01 | 11.07 |
![]() Viatris Inc. | 224.4 | NA | 0.06 | 2.73 | 0.0 | 0.03 | 0.04 | 16.81 |
![]() Catalent, Inc. | 211.02 | NA | 2.06 | 0.2 | -0.28 | -0.01 | NA | 19.96 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Fsd Pharma Inc | Buy | $6.6M | -98.04% | NA | 0.0% |
![]() Neurocrine Biosciences Inc. | Buy | $14.7B | 67.01% | 39.75 | 18.65% |
![]() Haleon Plc Spon Ads | Buy | $41.0B | 23.35% | 29.9 | 9.64% |
![]() Zoetis Inc. | Buy | $82.0B | 57.03% | 34.62 | 27.38% |
![]() Viatris Inc. | Hold | $14.2B | -28.03% | 224.4 | -0.37% |
![]() Catalent, Inc. | Hold | $10.6B | 2.08% | 211.02 | -28.44% |
Insights on Fsd Pharma Inc
In the last 1 year, Neurocrine Biosciences Inc. has given 45.5% return, outperforming this stock by 131.8%
In the last 3 years, Neurocrine Biosciences Inc. has given 52.6% return, outperforming this stock by 143.5%
AdvisorShares Investments, LLC
Renaissance Technologies Corp
Scotia Capital Inc
UBS Group AG
Susquehanna International Group, LLP
Group One Trading, LP
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Organization | Fsd Pharma Inc |
Employees | 0 |
CEO | Mr. Zeeshan Saeed |
Industry | Process Industries |
A Spac I Acquisition Corp
$0.15
-2.09%
Keyarch Acquisition Corp
$0.15
-2.09%
Connexa Sports Technologies Inc
$0.15
-2.09%
Us Value Etf
$0.15
-2.09%
First Wave Biopharma Inc
$0.15
-2.09%
Global X Msci Next Emerging
$0.15
-2.09%
Fat Projects Acquisition Corp
$0.15
-2.09%
Capital Link Global Fintech
$0.15
-2.09%
Applied Uv Inc
$0.15
-2.09%